EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Distinct Effects of Nonselective Rho‐Kinase Inhibitor Fasudil and Selective Rho‐Kinase 2 Inhibitor KD025 on Serotonin and Dopamine Release in the Nucleus Accumbens of Mice

Rinako Tanaka, Wenjun Zhu, Taku Nagai, Toshitaka Nabeshima, Kozo Kaibuchi, Norio Ozaki, Hiroaki Ikesue, Hiroyuki Mizoguchi iD, Kiyofumi Yamada iD

Neuropsychopharmacology Reports · 2026-06 · 46 (2)

DOI: 10.1002/npr2.70124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 27.04.2026. Verfasst von Rinako Tanaka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, Dopamine, Serotonin, Nucleus Accumbens. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have indicated that the Rho GTPase family and Rho‐kinases are associated with psychiatric diseases, such as schizophrenia. Two subtypes of Rho‐kinase, Rho‐kinases 1 and 2, regulate actin dynamics and mediate neurite outgrowth, spine morphology in neurons, and neurotransmitter release in vitro and ex vivo. However, the precise role of Rho‐kinases in neurotransmitter release in vivo remains unclear. To clarify the role of Rho‐kinases 1 and 2 in serotonin and dopamine release in the nucleus accumbens (NAc) of mice in vivo, we investigated the effect of a nonselective Rho‐kinase inhibitor, fasudil, and a selective Rho‐kinase 2 inhibitor, KD025, using an in vivo microdialysis technique. Fasudil perfusion (1–20 μM) into the NAc increased the basal extracellular serotonin level but did not affect dopamine levels, whereas KD025 (10–20 μM) had little effect on basal serotonin and dopamine levels. Notably, fasudil perfusion into the NAc suppressed depolarization‐induced serotonin and dopamine release in a dose‐dependent manner, whereas KD025 selectively suppressed depolarization‐induced serotonin release. Our results suggested that Rho‐kinases 1 and 2 are associated with dopamine and serotonin release, respectively, and that both may have significant but distinct roles in the regulation of serotonin and dopamine release in the NAc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineDopamineSerotoninNucleus Accumbensrho-Associated KinasesProtein Kinase InhibitorsAnimalsMiceMaleDose-Response Relationship, DrugMicrodialysis

Stichwörter der Autor:innen

dopamineexocytosishigh K+rho‐kinaseserotonin

Substanzen

fasudil1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineDopamineSerotoninrho-Associated KinasesProtein Kinase InhibitorsRock2 protein, mouse

Autor:innen und Institutionen

  • Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University, Toyoake, Aichi, Japan.
  • Fujita Mind-Brain Research & Innovation center for Drug Generation (Fujita Mind-BRIDGe), Toyoake, Aichi, Japan.
  • Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Medical Sciences, Toyoake, Aichi, Japan.
  • Japanese Drug Organization of Appropriate Use and Research, Nagoya, Aichi, Japan.
  • Division of Cell Biology, ICBS, Fujita Health University, Toyoake, Aichi, Japan.

ORCID-Profile: Hiroyuki Mizoguchi, Kiyofumi Yamada

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Tanaka, R., Zhu, W., Nagai, T., Nabeshima, T., Kaibuchi, K., Ozaki, N., Ikesue, H., Mizoguchi, H., & Yamada, K. (2026). Distinct Effects of Nonselective Rho‐Kinase Inhibitor Fasudil and Selective Rho‐Kinase 2 Inhibitor KD025 on Serotonin and Dopamine Release in the Nucleus Accumbens of Mice. Neuropsychopharmacology Reports, 46(2). https://doi.org/10.1002/npr2.70124

Vancouver

Tanaka R, Zhu W, Nagai T, Nabeshima T, Kaibuchi K, Ozaki N, et al. Distinct Effects of Nonselective Rho‐Kinase Inhibitor Fasudil and Selective Rho‐Kinase 2 Inhibitor KD025 on Serotonin and Dopamine Release in the Nucleus Accumbens of Mice. Neuropsychopharmacology Reports. 2026;46(2). doi:10.1002/npr2.70124

BibTeX
@article{Tanaka2026,
  author = {Tanaka, Rinako and Zhu, Wenjun and Nagai, Taku and Nabeshima, Toshitaka and Kaibuchi, Kozo and Ozaki, Norio and Ikesue, Hiroaki and Mizoguchi, Hiroyuki and Yamada, Kiyofumi},
  title = {Distinct Effects of Nonselective Rho‐Kinase Inhibitor Fasudil and Selective Rho‐Kinase 2 Inhibitor KD025 on Serotonin and Dopamine Release in the Nucleus Accumbens of Mice},
  journal = {Neuropsychopharmacology Reports},
  year = {2026},
  volume = {46},
  number = {2},
  doi = {10.1002/npr2.70124}
}
Kostenlos starten →